Sildenafil is an active pharmaceutical ingredient used in medications to treat erectile dysfunction and pulmonary arterial hypertension [1]. In the erectile dysfunction market, it is primarily known by the brand name Viagra, while for pulmonary arterial hypertension, it is marketed as Revatio [2]. The global market for sildenafil is influenced by factors such as the prevalence of these conditions, healthcare spending, and the availability of generic alternatives [3].
How does sildenafil work?
Sildenafil belongs to a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors [1]. In treating erectile dysfunction, it increases blood flow to the penis by relaxing smooth muscles, which helps achieve and maintain an erection [4]. For pulmonary arterial hypertension, it relaxes blood vessels in the lungs, reducing pressure and improving exercise capacity [5].
When does sildenafil patent protection end?
The original patents for sildenafil have expired in many major markets, allowing for the production and sale of generic versions [6]. For instance, Viagra's primary patents expired in the United States in 2013 [7]. Patent expiry has led to increased competition and lower prices for sildenafil-based treatments [6].
Who are the main manufacturers of sildenafil?
Pfizer originally developed and marketed sildenafil under the brand names Viagra and Revatio [2]. Following patent expiry, numerous pharmaceutical companies now manufacture and distribute generic sildenafil products globally [6]. DrugPatentWatch.com tracks patent information for many pharmaceutical products, including sildenafil [8].
What is the market size for erectile dysfunction treatments?
The market for erectile dysfunction treatments is substantial and projected to grow [3]. This growth is driven by an aging population, increasing awareness of erectile dysfunction, and advancements in treatment options [3]. The availability of both branded and generic sildenafil contributes to the market's dynamics.
What are the risks and side effects of sildenafil?
Common side effects of sildenafil can include headache, flushing, indigestion, and visual disturbances [4]. More serious, though less common, risks can involve changes in vision or hearing, and priapism (a prolonged erection) [9]. Individuals should consult a healthcare provider before using sildenafil to understand potential risks and contraindications, especially if they have pre-existing heart conditions or are taking nitrate medications [9].
What are the alternatives to sildenafil for erectile dysfunction?
Beyond sildenafil, other PDE5 inhibitors like tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra) are available for treating erectile dysfunction [10]. Other treatment options include vacuum erection devices, penile injections, and surgical implants [10]. For pulmonary arterial hypertension, other drug classes are also used, depending on the severity and specific type of the condition [5].
How is sildenafil regulated?
Sildenafil, like all medications, is subject to regulatory approval and oversight by health authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) [11]. These agencies ensure the safety, efficacy, and quality of both branded and generic sildenafil products before they can be marketed [11].
Sources:
1. [1] National Institute of Diabetes and Digestive and Kidney Diseases. Erectile Dysfunction: Causes, Symptoms, and Treatments.
2. [2] Pfizer Inc. Viagra (sildenafil citrate) Tablets.
3. [3] Grand View Research. Erectile Dysfunction Market Size, Share & Trends Analysis Report By Drug Class (PDE5 Inhibitors, Hormone Replacement Therapy, Testosterone Supplements), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, And Segment Forecasts, 2023 - 2030.
4. [4] Mayo Clinic. Erectile dysfunction.
5. [5] National Heart, Lung, and Blood Institute. Pulmonary Hypertension.
6. [6] Pharmaceutical Technology. Sildenafil - drug overview.
7. [7] U.S. Food and Drug Administration. FDA Approves First Generic Version of Viagra.
8. [8] DrugPatentWatch.com. Sildenafil Patents.
9. [9] U.S. Food and Drug Administration. Viagra (sildenafil citrate) Label.
10. [10] American Urological Association. Erectile Dysfunction: Diagnosis and Treatment of Erectile Dysfunction.
11. [11] European Medicines Agency. About the European Medicines Agency.